MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Interest Expenses came in at $3.9 million in Q4 2025, up 43.35% YoY from $2.7 million in Q4 2024, and up 27.96% on a QoQ basis from $3.1 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Interest Expenses data on file, last reported at $3.9 million in Q4 2025.

  • Quarterly Interest Expenses rose 43.35% year-over-year to $3.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 1.27% YoY) and the FY2025 annual result came in at $174.8 million, up 17.02% from the prior year.
  • Interest Expenses rose to $3.9 million in Q4 2025, from $3.1 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8.6 million in Q1 2025 to a low of $119000.0 in Q4 2021.
  • A 5-year average of $2.7 million and a median of $3.0 million in 2023 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2021 — Interest Expenses plunged 93.21% — and 2022, when it surged 1026.05%.
  • Tracing MGTX's Interest Expenses over 5 years: stood at $119000.0 in 2021, then surged by 1026.05% to $1.3 million in 2022, then jumped by 143.13% to $3.3 million in 2023, then retreated by 16.02% to $2.7 million in 2024, then surged by 43.35% to $3.9 million in 2025.
  • The last three Interest Expenses figures came in at $3.9 million (Q4 2025), $3.1 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.51 Mn
Dec 31, 2025 3.06 Mn
Sep 30, 2025 3.07 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 3.04 Mn
Dec 31, 2024 3.41 Mn
Sep 30, 2024 3.36 Mn
Jun 30, 2024 3.25 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 3.45 Mn
Sep 30, 2023 3.38 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 3.06 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 1.89 Mn
Jun 30, 2022 82,000.00
Mar 31, 2022 77,000.00
Dec 31, 2021 119,000.00
Sep 30, 2021 59,000.00
Jun 30, 2021 51,000.00